Clinical Trial Update: Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies [Phase 4]

View source ↗

Summary

Phase 4 trial update on topical anti-inflammatory drugs (prednisolone, nepafenac, and ketorolac) to manage intraoperative mydriasis during cataract procedures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Ketorolac (Ketorolac tromethamine)
• Nepafenac (nepafenac)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Clinica Oftamologica Zona Sul | Conditions: Cataract | Phase 4 | Status: UNKNOWN